Clinic of Dermatovenereology, Clinical Center of Serbia, Belgrade, Serbia.
School of Medicine, University of Belgrade, Belgrade, Serbia.
Fam Pract. 2024 Aug 14;41(4):615-617. doi: 10.1093/fampra/cmad043.
Acne vulgaris is one of the most frequent visits to primary care physicians and dermatologists alike. Isotretinoin is the backbone of acne treatment. In most countries, depending on the health care system, isotretinoin is prescribed by dermatologists but primary care physicians are a part of the follow-up and interpreting analysis. Adverse effects of isotretinoin on the kidney and urinary system are mostly limited to sparse case reports. Specifically, gross and microscopic haematuria is not mentioned to be associated with isotretinoin. Lack of data regarding these adverse effects can lead to doubt regarding further patient management not only with dermatologists but also primary care physicians.
We report a 16-year-old male patient with isotretinoin-induced haematuria with multiple episodes and subsequent challenge and de-challenge. No personal or familial history of nephrological disease was present. Ultrasound imaging and nephrology workup was within normal limits. Other aetiologies were excluded. Nephrology consult stated there was no contraindication for isotretinoin use and was reinstated at 0.6 m/kg/day. More frequent observation was indicated until completion of isotretinoin.
Our case raises awareness to other dermatologists and primary care physicians that haematuria can be secondary to isotretinoin but not a contraindication for further use if asymptomatic and microscopic. More extensive evaluation and monitoring should be done if the patient is symptomatic with other abnormalities and symptoms. Urinalysis should be a part of routine follow-up monitoring in patients on isotretinoin. Furthermore, delineating and differentiating when to refer to a nephrologist is essential for physicians, patients, and the health care system overall.
寻常痤疮是初级保健医生和皮肤科医生都经常接诊的疾病之一。异维 A 酸是痤疮治疗的基础。在大多数国家,根据医疗保健系统的不同,异维 A 酸由皮肤科医生开具,但初级保健医生也参与随访和解读分析。异维 A 酸对肾脏和泌尿系统的不良影响大多局限于少数病例报告。具体来说,血尿的肉眼血尿和镜下血尿与异维 A 酸无关尚未被提及。由于缺乏关于这些不良反应的数据,不仅会使皮肤科医生对进一步的患者管理产生怀疑,也会使初级保健医生对进一步的患者管理产生怀疑。
我们报告了一例 16 岁男性患者,他因异维 A 酸引起血尿,反复发作,随后进行了挑战和停药试验。患者无个人或家族性肾病病史。超声影像学和肾脏病学检查均在正常范围内。排除了其他病因。肾脏病学咨询认为异维 A 酸的使用没有禁忌症,并重新开始以 0.6 m/kg/天的剂量使用。指示更频繁地观察,直到异维 A 酸治疗完成。
我们的病例提醒其他皮肤科医生和初级保健医生注意,血尿可能是异维 A 酸引起的,但如果无症状和镜下血尿,则不是进一步使用的禁忌症。如果患者出现其他异常和症状,则应进行更广泛的评估和监测。如果患者正在服用异维 A 酸,应将尿分析作为常规随访监测的一部分。此外,明确何时向肾病医生转诊对于医生、患者和整个医疗保健系统都至关重要。